Company

Sarcomatrix

Biotechnology Research Reno, Nevada, United States 5 employees

Employees: 5
Contacts: 2
Emails: 2

www.sarcomatrix.com LinkedIn Crunchbase

Sarcomatrix Overview

Headquarters: Reno, Nevada, United States
Website: www.sarcomatrix.com
Industry: Biotechnology Research
Employees: 5
Founded: 2022
Funding: 300.0K
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Muscular Dystrophy Rare Disease muscle wasting anti aging Congenital Muscular Dystrophy small molecules protein replacement α7β1 integrin enhancers sarcopenia Cachexia Seed Investment Angel Investment

About Sarcomatrix

Sarcomatrix, Inc. is a bio-pharmaceutical company pioneering novel therapeutics that leverage our understanding of muscle biology and tissue regeneration to develop therapies that have potential for broad clinical applicability across multiple disease areas of high unmet need. Our current focus is muscular dystrophy. Muscular dystrophy, a rare disease without a cure, reduces a patient's average life expectancy to 26 years. Our goal is to more than double their life expectancy. Our IP protected vast portfolio of small molecules a7β1 integrin activators and laminin proteins, used as single agents or in combination with cell and gene therapy, may ultimately cure muscular dystrophy.

Sarcomatrix Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Sarcomatrix Org Chart

Sample employees and titles

Name	Title	Location	Contact
David Craig	Chief Executive Officer at Sarcomatrix		View
David Maine	Technology	Reno, Nevada, United States	Email
Lea Geguna	Striving to Help Us Live Longer		View
David R. Craig, Mba	Co-founder & CEO @ Sarcomatrix - Mba	San Francisco Bay Area, United States	Email